医学
哮喘
相(物质)
内科学
物理疗法
化学
有机化学
作者
Janet M. Griffiths,Tuyet‐Hang Pham,Eileen Wang,Chris Ambrose,Neil Martin,Jane R. Parnes,Andrew Lindsley,Gillian Hunter,Gene Colice,John J Oppenheimer
标识
DOI:10.1016/j.jaci.2021.12.085
摘要
Tezepelumab, a human monoclonal antibody, blocks the actions of thymic stromal lymphopoietin (TSLP) and reduces downstream airway inflammation. To provide mechanistic insight into the clinical effects of tezepelumab in patients with severe asthma, we evaluated the effect of tezepelumab on levels of airway and circulating inflammatory cytokines and biomarkers during the phase 3, randomized, placebo-controlled NAVIGATOR study (NCT03347279).
科研通智能强力驱动
Strongly Powered by AbleSci AI